Lifestance Health Group Inc (LFST)

$5.71

+0.02

(+0.35%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Lifestance Health Group Inc

  • Increasing Revenue

    Revenue is up for the last 15 quarters, 45.45M → 280.60M (in $), with an average increase of 10.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -61.58M → -44.95M (in $), with an average increase of 37.0% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 80.5%

Performance

  • $5.66
    $5.80
    $5.71
    downward going graph

    0.88%

    Downside

    Day's Volatility :2.41%

    Upside

    1.55%

    downward going graph
  • $4.74
    $9.59
    $5.71
    downward going graph

    16.99%

    Downside

    52 Weeks Volatility :50.57%

    Upside

    40.46%

    downward going graph

Returns

PeriodLifestance Health Group IncSector (Health Care)Index (Russel 2000)
3 Months
-15.83%
-0.7%
0.0%
6 Months
-6.26%
6.6%
0.0%
1 Year
-27.61%
3.7%
-1.5%
3 Years
-74.02%
14.0%
-21.8%

Highlights

Market Capitalization
2.1B
Book Value
$3.77
Earnings Per Share (EPS)
-0.51
Wall Street Target Price
8.79
Profit Margin
-17.64%
Operating Margin TTM
-28.0%
Return On Assets TTM
-5.18%
Return On Equity TTM
-12.64%
Revenue TTM
1.1B
Revenue Per Share TTM
2.87
Quarterly Revenue Growth YOY
22.3%
Gross Profit TTM
237.0M
EBITDA
-97.0M
Diluted Eps TTM
-0.51
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.28
EPS Estimate Next Year
-0.21
EPS Estimate Current Quarter
-0.09
EPS Estimate Next Quarter
-0.11

Analyst Recommendation

Buy
    61%Buy
    38%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Lifestance Health Group Inc(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
5
5
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 53.94%

Current $5.71
Target $8.79

Company Financials

FY19Y/Y Change
Revenue
212.5M
-
Net Income
5.7M
-
Net Profit Margin
2.67%
-
FY20Y/Y Change
Revenue
377.2M
↑ 77.5%
Net Income
-38.1M
↓ 771.55%
Net Profit Margin
-10.09%
↓ 12.76%
FY21Y/Y Change
Revenue
667.5M
↑ 76.96%
Net Income
-307.2M
↑ 706.93%
Net Profit Margin
-46.02%
↓ 35.93%
FY22Y/Y Change
Revenue
859.5M
↑ 28.77%
Net Income
-215.6M
↓ 29.83%
Net Profit Margin
-25.08%
↑ 20.94%
FY23Y/Y Change
Revenue
1.1B
↑ 22.82%
Net Income
-186.3M
↓ 13.59%
Net Profit Margin
-17.64%
↑ 7.44%
Q3 FY22Q/Q Change
Revenue
217.6M
↑ 3.83%
Net Income
-37.9M
↓ 44.92%
Net Profit Margin
-17.4%
↑ 15.4%
Q4 FY22Q/Q Change
Revenue
229.4M
↑ 5.42%
Net Income
-46.7M
↑ 23.26%
Net Profit Margin
-20.34%
↓ 2.94%
Q1 FY23Q/Q Change
Revenue
252.6M
↑ 10.13%
Net Income
-34.2M
↓ 26.61%
Net Profit Margin
-13.56%
↑ 6.78%
Q2 FY23Q/Q Change
Revenue
259.6M
↑ 2.77%
Net Income
-45.5M
↑ 32.81%
Net Profit Margin
-17.52%
↓ 3.96%
Q3 FY23Q/Q Change
Revenue
262.9M
↑ 1.28%
Net Income
-61.6M
↑ 35.41%
Net Profit Margin
-23.42%
↓ 5.9%
Q4 FY23Q/Q Change
Revenue
280.6M
↑ 6.74%
Net Income
-45.0M
↓ 26.99%
Net Profit Margin
-16.02%
↑ 7.4%
FY19Y/Y Change
Total Assets
280.8M
-
Total Liabilities
447.1M
-
FY20Y/Y Change
Total Assets
1.6B
↑ 459.06%
Total Liabilities
571.9M
↑ 27.9%
FY21Y/Y Change
Total Assets
1.9B
↑ 22.77%
Total Liabilities
382.1M
↓ 33.19%
FY22Y/Y Change
Total Assets
2.2B
↑ 12.8%
Total Liabilities
655.1M
↑ 71.47%
FY23Y/Y Change
Total Assets
2.2B
↑ 2.73%
Total Liabilities
804.3M
↑ 22.76%
Q3 FY22Q/Q Change
Total Assets
2.0B
↑ 0.56%
Total Liabilities
448.2M
↑ 2.47%
Q4 FY22Q/Q Change
Total Assets
2.2B
↑ 9.81%
Total Liabilities
655.1M
↑ 46.19%
Q1 FY23Q/Q Change
Total Assets
2.2B
↓ 0.7%
Total Liabilities
653.4M
↓ 0.26%
Q2 FY23Q/Q Change
Total Assets
2.2B
↑ 0.57%
Total Liabilities
676.0M
↑ 3.46%
Q3 FY23Q/Q Change
Total Assets
2.2B
↑ 0.19%
Total Liabilities
720.0M
↑ 6.51%
Q4 FY23Q/Q Change
Total Assets
2.2B
↑ 2.67%
Total Liabilities
804.3M
↑ 11.7%
FY19Y/Y Change
Operating Cash Flow
17.0M
-
Investing Cash Flow
-73.4M
-
Financing Cash Flow
48.5M
-
FY20Y/Y Change
Operating Cash Flow
-8.5M
↓ 150.05%
Investing Cash Flow
-861.2M
↑ 1073.65%
Financing Cash Flow
912.3M
↑ 1782.41%
FY21Y/Y Change
Operating Cash Flow
9.4M
↓ 210.39%
Investing Cash Flow
-194.1M
↓ 77.46%
Financing Cash Flow
313.9M
↓ 65.6%
FY22Y/Y Change
Operating Cash Flow
52.8M
↑ 460.39%
Investing Cash Flow
-139.5M
↓ 28.14%
Financing Cash Flow
47.3M
↓ 84.94%
Q3 FY22Q/Q Change
Operating Cash Flow
5.7M
↓ 26.85%
Investing Cash Flow
-20.3M
↓ 46.71%
Financing Cash Flow
8.2M
↓ 36.5%
Q4 FY22Q/Q Change
Operating Cash Flow
35.9M
↑ 526.84%
Investing Cash Flow
-30.3M
↑ 49.45%
Financing Cash Flow
12.7M
↑ 54.58%
Q1 FY23Q/Q Change
Operating Cash Flow
-7.9M
↓ 121.97%
Investing Cash Flow
-27.5M
↓ 9.07%
Financing Cash Flow
-4.9M
↓ 138.6%
Q2 FY23Q/Q Change
Operating Cash Flow
-434.0K
↓ 94.5%
Investing Cash Flow
-11.6M
↓ 57.96%
Financing Cash Flow
23.3M
↓ 577.21%

Technicals Summary

Sell

Neutral

Buy

Lifestance Health Group Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lifestance Health Group Inc
Lifestance Health Group Inc
-9.25%
-6.26%
-27.61%
-74.02%
-74.02%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
-0.32%
10.42%
-15.35%
-50.85%
-51.82%
Hca Holdings, Inc.
Hca Holdings, Inc.
-4.93%
28.25%
14.58%
59.59%
169.9%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-4.36%
72.26%
44.71%
82.68%
310.08%
Universal Health Services Inc.
Universal Health Services Inc.
-9.74%
24.99%
16.98%
9.58%
28.53%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-6.85%
62.1%
52.88%
15.22%
144.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lifestance Health Group Inc
Lifestance Health Group Inc
NA
NA
NA
-0.28
-0.13
-0.05
NA
3.77
Fresenius Medical Care Ag
Fresenius Medical Care Ag
20.44
20.44
0.39
2.04
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
17.0
17.0
1.44
20.64
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.21
17.21
2.2
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
16.27
16.27
1.87
13.45
0.12
0.05
0.0
91.53
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.49
17.49
1.16
9.01
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lifestance Health Group Inc
Lifestance Health Group Inc
Buy
$2.1B
-74.02%
NA
-17.64%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$10.9B
-51.82%
20.44
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$85.3B
169.9%
17.0
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$9.7B
310.08%
17.21
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$11.2B
28.53%
16.27
5.03%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.3B
144.38%
17.49
5.7%

Institutional Holdings

  • TPG GP A, LLC

    46.04%

  • Summit Partners L P

    12.01%

  • FMR Inc

    9.09%

  • BlackRock Inc

    2.03%

  • Durable Capital Partners LP

    2.00%

  • Vanguard Group Inc

    1.99%

Corporate Announcements

  • Lifestance Health Group Inc Earnings

    Lifestance Health Group Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

lifestance health is a behavioral health care company focused on providing evidenced-based, medically driven treatment services for children, adolescents and adults suffering from a variety of mental health issues in care settings that include acute inpatient, partial hospitalization, intensive outpatient, outpatient, community-based and in-home. at lifestance, patient care is paramount – the driving force in everything we do. we are committed to state-of-the-art clinical excellence, to partnership and collaboration with other treating health care providers to ensure continuity of care, to utilization of data to individually tailor our services for continual improvement in outcomes, and to empowering our patients to make informed choices and help them achieve their goals. all in a compassionate and safe environment that provides education, support and best practices in integrated care.

Organization
Lifestance Health Group Inc
Employees
9325
CEO
Mr. Kenneth Alan Burdick
Industry
Healthcare

Discover More

FAQs